Injection of AJCC stage IIB, IIC, III, and IV melanoma patients with human and mouse gp100 DNA [melanoma DNA vaccine]: A phase I trial to assess safety and immune response
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melanoma DNA vaccine; Melanoma vaccine gp100
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 12 Mar 2013 Biomarkers information updated
- 19 Apr 2009 Results have been published in the proceedings of the 100th Annual Meeting of the American Association for Cancer Research
- 23 Aug 2006 Status change